QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.104.003723v1 66/6/1406    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paulos, C. M. Articles by Low, P. S. Search for Related Content PubMed PubMed Citation Articles by Paulos, C. M. Articles by Low, P. S.

Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery

Department of Chemistry, Purdue University, West Lafayette, Indiana (C.M.P., M.T., P.S.L.); and Endocyte, Inc., Lafayette, Indiana (J.A.R., C.P.L.)

Folate receptor-targeted cancer therapies constitute a promising treatment for the approximately one third of human cancers that overexpress the folate receptor (FR). However, the potencies of all folate-receptor targeted therapies depend on 1) the rate of folate-linked drug conjugate binding to the cancer cell surface, 2) the dose of folate conjugate that will saturate tumor cell surface FR in vivo, 3) the rate of FR internalization, unloading, and recycling back to the tumor cell surface for another round of conjugate uptake, and 4) the residence time of the folate conjugate before its metabolism or release from the cell. Because little information exists on any of these processes, we have undertaken to characterize them on both cancer cells in culture and solid tumors in live mice. We quantitate here the properties of FR saturation, internalization, recycling, and unloading in several cultured cancer cell lines and murine tumor models, and we describe the conditions that should maximize both the potencies and specificities of folate receptor-targeted therapies in vivo.

Address correspondence to: Philip S. Low, Department of Chemistry, 560 Oval Drive, West Lafayette, IN 47907. E-mail: plow{at}purdue.edu

This article has been cited by other articles:

				H. Chen, J. Yang, P. S. Low, and J.-X. Cheng Cholesterol Level Regulates Endosome Motility via Rab Proteins Biophys. J., February 15, 2008; 94(4): 1508 - 1520. [Abstract] [Full Text] [PDF]

				A. Qiu, S. H. Min, M. Jansen, U. Malhotra, E. Tsai, D. C. Cabelof, L. H. Matherly, R. Zhao, M. H. Akabas, and I. D. Goldman Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1669 - C1678. [Abstract] [Full Text] [PDF]

				W. He, H. Wang, L. C. Hartmann, J.-X. Cheng, and P. S. Low In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry PNAS, July 10, 2007; 104(28): 11760 - 11765. [Abstract] [Full Text] [PDF]

				J. Yang, H. Chen, I. R. Vlahov, J.-X. Cheng, and P. S. Low Characterization of the pH of Folate Receptor-Containing Endosomes and the Rate of Hydrolysis of Internalized Acid-Labile Folate-Drug Conjugates J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 462 - 468. [Abstract] [Full Text] [PDF]